#1 Worldwide

Europe = EU + Norway, Switzerland

Derived from IMS data Q3 02/YTD

# of Patients

122 K

72 K+

46 K

58 K+

AVONEX®

Betaseron®

Rebif®

Copaxone®

Previous slide

Next slide

Back to first slide

View graphic version